#140 : Combined Use of Letrozole, Cabergoline and GnRH Antagonist to Prevent Ovarian Hyperstimulation Syndrome Completely in Polycystic Ovarian Syndrome Treatment

#140 : Combined Use of Letrozole, Cabergoline and GnRH Antagonist to Prevent Ovarian Hyperstimulation Syndrome Completely in Polycystic Ovarian Syndrome Treatment

Background and Aims: The main difficulty to treat polycystic ovarian syndrome (PCOS) is the possibility of ovarian hyperstimulation syndrome (OHSS). There are several clinical approaches to avoid dangerous complications of OHSS: laparoscopic ovarian drilling (LOD), in vitro maturation (IVM), and GnR...

Full description

Bibliographic Details
Main Authors: Yasuho Yanagihara, Motoharu Ohno, Tomoichiro Kuwazuru, Daisuke Nakajima, Motoi Nagayoshi, Izumi Tanaka, Atsushi Tanaka, Atsuo Itakura
Format: Article
Language:English
Published: World Scientific Publishing 2023-12-01
Series:Fertility & Reproduction
Online Access:https://www.worldscientific.com/doi/10.1142/S2661318223743254

Internet

https://www.worldscientific.com/doi/10.1142/S2661318223743254

Similar Items